Literature DB >> 12297263

GTP cyclohydrolase I induction in striatal astrocytes following intrastriatal kainic acid lesion.

Jane A Foster1, Patricia L Christopherson, Robert A Levine.   

Abstract

The cause of premature death of dopamine neurons in patients with Parkinson's disease remains unknown. It is speculated that damaging reactive species resulting from the metabolism of dopamine, nitric oxide, and tetrahydrobiopterin (BH(4)) may be involved. GTP cyclohydrolase I (GCH1) is the first and rate-limiting enzyme in the synthesis of BH(4), an essential cofactor for tyrosine hydroxylase and nitric oxide synthase in dopamine and nitric oxide production, respectively. Our studies have explored BH(4) metabolism in the nigrostriatal system following intrastriatal kainic acid lesion. We have demonstrated that 1 week following kainic acid there was an increase in striatal GCH1 mRNA, protein, and activity. There was also an elevation of BH(4) levels in the striatum. Part of the induction of GCH1 was localized in situ to astrocytes. Further, the striatal lesion caused death of both neurons and astrocytes in striatum, as shown by in situ end labeling. These novel observations suggest that the induction of GTP cyclohydrolase and BH(4) in striatal astrocytes may be mediating death of striatal neuronal and non-neuronal cells. This work supports existing and emerging reports that demonstrate the importance of dopamine metabolism in neuronal death of the nigrostriatal system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12297263     DOI: 10.1016/s0891-0618(02)00044-3

Source DB:  PubMed          Journal:  J Chem Neuroanat        ISSN: 0891-0618            Impact factor:   3.052


  2 in total

Review 1.  Tyrosine hydroxylase replacement in experimental Parkinson's disease with transvascular gene therapy.

Authors:  William M Pardridge
Journal:  NeuroRx       Date:  2005-01

2.  Suppression of astrocytic autophagy by αB-crystallin contributes to α-synuclein inclusion formation.

Authors:  Shen-Zhao Lu; Yong-Shun Guo; Pei-Zhou Liang; Shu-Zhen Zhang; Shu Yin; Yan-Qing Yin; Xiao-Min Wang; Fei Ding; Xiao-Song Gu; Jia-Wei Zhou
Journal:  Transl Neurodegener       Date:  2019-01-18       Impact factor: 8.014

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.